Biomarker of Diabetic Retinopathy
A
Ashay D. Bhatwadekar, PhD, MPHARM
Primary Investigator
Enrolling By Invitation
18 years and older
All
Phase
N/A
192 participants needed
3 Locations
Brief description of study
Diabetic retinopathy (DR) is a complication of diabetes in which blood vessels supplying
blood to the back of the eye (retina) are dysfunctional. This can lead to an improper supplyygen and nutrients to the retinal tissue, or it may trigger the formation of new blood
vessels in response to the oxygen/nutrient deficiency. Ultimately affecting the normal
vision. There is no known marker that will provide information on the health status ofblood vessels. Using highly specialized cells in the blood, this study will try to
discover a marker of DR.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Diabetic Retinopathy
-
Age: 18 Years
-
Gender: All
Inclusion Criteria:
- Ability to cooperate with imaging procedures.
- Health status: established type 2 diabetes
- No history of panretinal photocoagulation (PRP)
- No history of treatment with intravitreal agents for past 12 months
Exclusion Criteria:
- Previous or current malignancy
- Acute or chronic infection (HIV, hepatitis B or C, tuberculosis)
- Cerebral vascular accident or cerebral vascular procedure
- Current pregnancy
- History of organ transplantation
- Presence of a graft (to avoid any effect of the graft)
- History of previous vitrectomy
- Subjects with a history of age-related macular degeneration age-related maculardegeneration (AMD), glaucoma, uveitis, and branched or central vein occlusion.
Updated on
01 Aug 2024.
Study ID: 11656
Please visit our main page to search for other studies you may be interested in.
If you need help finding a study or have any questions, please contact us at inhealth@iu.edu
